Introduction
When materials are engineered to nanosize with a diameter ,100 nm, they acquire unique physical and chemical properties. Hence, with the rapid development and widespread application of nanoparticles (NPs) in many scientific fields, including cosmetics, the food industry, diagnostic medicine, electronics, and drug delivery, the environmental and occupational exposure of humans to NPs is dramatically increasing. The potential effects of NPs on human health have attracted special attention due to their small size and unique surface area; therefore, the detailed evaluation of their potential risk in vivo is essential.
Copper (Cu) is an essential trace element for the normal growth of humans and animals. 1 However, if the Cu intake exceeds the range of biological tolerance, it can exert toxic side effects, including kidney damage, hemolysis, jaundice, and liver and gastrointestinal distress. 2, 3 Copper nanoparticles (Cu NPs), one of the manufactured NPs, are now industrially produced and available commercially. Recently, Cu NP has shown great promise as an antibacterial material [4] [5] [6] [7] and even been used as intrauterine contraceptive device (IUD). [8] [9] [10] [11] [12] [13] [14] Recently, a new type of nano-Cu IUD was invented by However, numerous studies have unequivocally indicated that exposure to Cu NPs can result in adverse effects in vivo and in vitro. [16] [17] [18] [19] [20] For instance, a previous study demonstrated that the exposure of mice to Cu NPs resulted in severe kidney, liver, and spleen impairment. 16 Another study further revealed that the nephrotoxicity of Cu NPs was highly correlated with significant alterations in the expression of many genes, such as those involved in oxidative phosphorylation, the cell cycle, the mitogen-activated protein kinase signaling pathway, and glutathione metabolism. 21 In addition, evidence has indicated that Cu NPs are translocated to the brain and affect neurotransmitter levels, [21] [22] [23] which may influence hormone secretion in the pituitary gland and female reproductive functions.
Recent studies have reported that exposure to some nanomaterials results in reproductive system toxicity. For instance, titanium dioxide NPs are able to accumulate in the ovaries and cause ovarian damage, resulting in an imbalance of mineral element distribution and sex hormones, impaired fertility, and changes in gene expression. 24 The ovarian injury may be associated with alteration of inflammation-related or follicular-atresia-related cytokine expression. 25 In addition, gold NPs can enter Chinese hamster ovary cells through the endocytic pathway, 26 infiltrate rat ovarian granulosa cells and subcellular organelles, and alter in vitro estrogen accumulation. 27 Moreover, mitogen-activated protein kinase cellular signal transduction pathways in mammalian cells can be activated by silicon carbide nanowires. 28 Furthermore, evidence has shown that chronic exposure of Enchytraeus albidus worms to Cu NPs results in lower reproductive output compared to exposure to CuCl 2 salt. 29 The application of Cu NPs in IUD increases the likelihood of exposure of the general population to Cu NPs; however, whether Cu NPs can migrate to the ovaries of mammals and affect reproduction has so far remained unclear. Therefore, we hypothesized that the ovaries might also be target organs of toxicity in mammals exposed to Cu NPs.
In this study, the accumulation of Cu NPs, ovarian pathological changes, ovarian ultrastructure, expression levels of the apoptotic proteins, oxidative stress, and microarray analysis of the rat ovary were investigated to explore the mechanism of ovarian dysfunction induced by Cu NPs in rats.
Materials and methods

Preparation and characterization of cu NPs
Cu NPs were obtained from Da Yu Medical Instrument Co Ltd (Wuhan, Hubei, China). The average particle size and morphology were measured using scanning electron microscopy (SEM). The purity of the Cu NPs was determined by energy-dispersive X-ray spectroscopy (EDS). Hydroxypropyl methylcellulose (HPMC) was obtained from Shanghai Colorcon Coating Technology Limited (Shanghai, People's Republic of China). A 1% HPMC solution (w/v) was used as the suspending agent. The Cu NP powder was suspended in 1% HPMC solution (w/v) inside a specially designed glove box that was filled with dry argon gas to prevent oxidation. To ensure that the Cu NPs did not aggregate, the solutions containing Cu NPs were resuspended by sonication for 15-20 min and mechanical vibration for 2 min, and the time interval from preparation to injection was ,20 min.
animals and treatment
Sexually mature female Sprague Dawley rats with an age of 10 weeks and a mean weight of 260±20 g were obtained from the Experimental Animal Center of Tongji Medical College, Huazhong University of Science and Technology. The rats were housed in cages under specific-pathogen-free (SPF) conditions. The rats were allowed to acclimatize in an isolated animal room with a 12-h light/dark cycle for at least 5 days before the experiment was carried out. During this period, the conditions were strictly controlled at a constant temperature of 24°C±2°C and a relative humidity of 50%±10%. The rats were provided with distilled water and sterilized food ad libitum. The Ethical Committee of Tongji Medical College, Huazhong University of Science and Technology approved this research, and the protocols for animal care and treatment were in accordance with their guidelines for animal experiments.
Based on data from the Chen et al 16 study, the LD 50 (median lethal dose) of Cu NPs in rats is 413 mg/kg body weight (BW). After acclimatization, the animals were weighed and randomly assigned to four subgroups (each group n=6), including a control group receiving 1% HPMC and three treatment groups that were exposed to Cu NPs via intraperitoneal injection at doses of 12.5 (Nano-Cu High), 6.25 (Nano-Cu Med), or 3.12 (Nano-Cu Low) mg/kg/d for 14 days. These amounts correspond to human exposures of ~0.03-0.14 g of Cu NPs based on a BW of 70 kg. The injection volumes of the Cu NP suspensions were calculated based on the most recently recorded weights of the rats, and 
5961
Ovarian toxicity of cu NPs the Cu NPs were administered to the rats by injection every day for 14 days. During the experiment, the animals were examined daily for any clinical signs of toxicity or mortality. BW was measured once every 2 days. After the final administration of Cu NPs, all of the rats were sacrificed, and blood samples were collected from the eye vein by rapidly removing the eyeball. Serum was collected by centrifuging blood samples at 2,500 rpm for 10 min, and the ovaries were collected and frozen at -80°C for Western blotting, oxidative stress, microarray, and quantitative real-time reverse-transcriptase polymerase chain reaction (qRT-PCR) analyses. The remaining tissues were fixed for histopathological examination and transmission electron microscopy (TEM).
Coefficient of ovary weight to BW
After weighing the body and ovaries, the coefficient of ovary weight to BW was calculated as ovary weight (wet weight, mg)/BW (g) × 100%.
sex hormone assays
The levels of sex hormones were evaluated by the serum levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), progesterone (P), and estradiol (E 2 ). All biochemical assays were conducted using a clinical automatic chemistry analyzer (Type 7170A; Hitachi Ltd., Tokyo, Japan).
histopathological examination and number of mature follicles
The histological examinations were carried out in compliance with protocols described previously. 30 The freshly isolated ovarian tissues were fixed with 4% paraformaldehyde and processed using routine histological techniques. After embedding in paraffin wax, 4 μm thick paraffin sections were cut, placed onto glass slides, and stained with hematoxylin and eosin (H&E) for histopathological observation using a light microscope.
Five typical glides were selected from each ovary. The interval between glides was .200 nm to avoid counting follicles repeatedly. The mature follicles are defined as oocytes with three or more layers of cuboidal granulosa cells with antral space. The index of mature follicles was calculated as a percentage of all follicles.
Observation of ovarian ultrastructure using TeM
The ovaries were dissected and immediately fixed with 2.5% glutaraldehyde in 0.1 M cacodylate buffer for 2 h.
The samples were then washed three times with 0.1 M cacodylate buffer and postfixed for 2 h in 1% osmium tetroxide in 0.1 M cacodylate buffer. The specimens were then washed three times using pure water, dehydrated by a graded ethanol series, and embedded using an EMbed 812 kit by a standard procedure. Ultrathin sections were obtained, double stained with uranyl acetate and lead citrate, and examined by TEM (JEOL/JEM 1400, Japan).
Oxidative stress biomarkers
Malondialdehyde (MDA) and superoxide dismutase (SOD) levels in the ovarian tissues were determined to assess oxidative stress and damage. The supernatants from ovarian tissue homogenates were obtained according to a method described previously. 31 Samples of the supernatant were maintained at 4°C until determination of their SOD and MDA concentrations using commercial assay kits (Nanjing Jiancheng Institute, Nanjing, Jiangsu, China). All samples were measured in duplicate.
assessment of apoptosis by TdT-mediated dUTP nick-end labeling (TUNel) staining
Apoptosis was examined by the TUNEL method. Briefly, ovarian tissues were fixed in 4% paraformaldehyde, embedded in paraffin, cut into sections with a thickness of 5 μm, and incubated with the TUNEL kit (Thermo Fisher Scientific, Waltham, MA, USA) in accordance with the manufacturer's instructions, followed by visualization under an inverted fluorescence microscope (Olympus Corporation, Tokyo, Japan). The apoptotic index was calculated as the percentage of TUNEL-positive cells in granulosa cells.
Western blotting
Western blot analysis was performed according to a previously described method. 32 The total protein was extracted from ovarian tissue using radioimmunoprecipitation assay buffer (ASPEN, AS1004, Wuhan, Hubei, People's Republic of China), and the protein lysate was separated on 10% polyacrylamide gels and then transferred to polyvinylidene difluoride (PVDF) membranes. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was used as an internal loading control. The blots were visualized with enhanced chemiluminescence (ECL) reagents. The quantitative analysis of each band was performed using ImageJ software (National Institutes of Health, Bethesda, MD, USA). Each experiment was repeated three times and the results were expressed as the average ± standard deviation (SD).
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Microarray and data analysis
The gene expression profiles of ovarian tissues isolated from the control rats and those treated with Cu NPs were compared via microarray analysis using an Illumina BeadChip (Affymetrix, Santa Clara, CA, USA). Briefly, total RNA was extracted using the TRIzol reagent (Thermo Fisher Scientific, Waltham, MA, USA) based on the manufacturer's instructions and stored at -80°C. RNA amplification is the standard method for RNA sample preparation for array analysis. 33 Total RNA was then submitted to Biostar Genechip Inc. (Shanghai, China); a bioanalyzer was used to analyze RNA quality, and cRNA was generated and labeled using the one-cycle target labeling method. The cRNA from each rat was hybridized to a single array based on the standard Illumina RNA Amplification Kit instructions for all arrays. Differentially expressed genes were identified using the Illumina BeadStudio data analysis software (Illumina, Inc., San Diego, CA, USA), and this program established the biological significance according to the Gene Ontology (GO) Consortium (http://www. geneontology.org/GO.doc.html). Student's t-test was used to identify differentially expressed genes between the two groups, with an absolute value of log2-fold change .1 and a P-value of ,0.05.
qrT Pcr
The expression levels of Hsd17b1, Hsd3b1, Hsd3b6, Hsd3b, Mt3, and Cebpb mRNA in the rat ovaries were quantified using qRT-PCR. GAPDH was included as an internal control, and the gene-specific mRNA expression was normalized to the GAPDH expression. The relative expression of target genes from the real-time PCR results was calculated according to 2 -ΔΔCt . 34 Each treatment was repeated at least three times. The primers for qRT-PCR (Table 1) were designed with Primer Express Software (Applied Biosystems, Foster City, CA, USA) according to the software guidelines.
statistical analysis
Statistical analysis was performed using SPSS 20 software (SPSS Inc., Chicago, IL, USA). The results were expressed as the mean ± SD. Multigroup comparisons of the differences of mean values among the data were carried out using oneway analysis of variance (ANOVA). Statistical significance for all tests was judged at a P-value of ,0.05.
Results
Physicochemical properties of cu NPs
As shown in Figure 1A and B, the average size of the Cu NPs was ~100 nm, and the morphology of the Cu NPs was observed from the SEM image. Furthermore, EDS spectra were used to confirm the presence of Cu, and the results are shown in Figure 1C . The results indicated strong Cu signals, along with weak oxygen peaks.
general toxicity
Symptoms of gastrointestinal and mental dysfunction, such as slight diarrhea, anorexia, and drowsiness, were observed in all rats that were administered the 12.5 mg/kg/d Cu NP dose. No abnormalities were observed in the control group or the other treated groups during the study period.
Coefficient of ovary weight to BW
The coefficients of ovary weight to BW for the rats treated with the Cu NPs are presented in Table 2 . In the 3.12, 6.25, and 
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Ovarian toxicity of cu NPs 12.5 mg/kg/d Cu NP-treated rats, the coefficients significantly decreased (P,0.05) compared to the control group, indicating ovarian damage in the rats.
reproductive endocrinology
The effects of the Cu NPs on sex hormones in the sera of female rats were examined and are presented in Table 3 . The group treated with 12.5 mg/kg/d of Cu NPs showed a marked reduction in FSH, LH, and P (P,0.05); however, the E 2 levels showed no significant changes (P.0.05). In addition, the levels of FSH, LH, P, and E 2 exhibited no significant changes for the rats treated with 6.25 or 3.12 mg/kg/d of Cu NPs compared to the control group.
histopathological evaluation and mature follicles
The ovarian histopathological changes are shown in Figure 2 . In comparison to the control group, significant ovarian histopathological changes were observed for the rats treated with high-dose (12.5 mg/kg/d) Cu NPs ( Figure 2B ), including ovarian atrophy, disturbance of follicular development, follicular atresia, and reduction in mature follicles. No severe damage to the ovarian tissue was observed for the 6.25 and 3.12 mg/kg/d Cu NP treatment groups ( Figure 2C and D) . Moreover, the 12.5 mg/kg/d Cu NP exposure group resulted in significant decreases in the percentage of mature follicles (P,0.05) (Figure 3 ).
Observation of ovarian ultrastructure
The TEM images of the ovarian cell ultrastructure are presented in Figure 3 . The ultrastructure of ovarian cells of the control group rats can be considered the normal cell structure ( Figure 4A ). In contrast, the ultrastructure of ovarian cells exposed to the high-dose Cu NPs (12.5 mg/kg/d) exhibited irregularity of the nuclear membrane, mitochondrial swelling, and cristae breakage ( Figure 4B) . Additionally, as shown in Figure 4C and D, the Cu NPs agglomerated in the cytoplasm of ovarian cells, suggesting that they were deposited in the ovarian cells. These results indicated that high-dose Cu NPs induced overt ovarian dysfunction in rats.
Oxidative stress analysis
To determine the effects of the various doses of Cu NPs on oxidative stress indices in rat ovarian tissues, the levels of SOD and MDA were analyzed. As shown in Table 4 , exposure to 12.5 mg/kg/d of Cu NPs caused a significant reduction in SOD activities (P,0.05), while the concentrations of MDA were significantly increased (P,0.05); however, compared to the control group, no significant changes in SOD or MDA levels were observed in the groups treated with 6.25 or 3.125 mg/kg/d of Cu NPs (P.0.05).
effect of cu NPs on DNa strand breakage
As shown in Figure 5 , the TUNEL assay was used for the detection of apoptosis in granulosa cells in rats of all the four groups. TUNEL-positive cells were observed in the granulosa Figure 1 Physicochemical properties of copper nanoparticles (cu NPs). Notes: (A and B) scanning electron microscopy (seM) image of cu NPs, the average size of the particle was 100 nm. (C) energy dispersive X-ray spectrum (eDs) of cu NPs. A strong peak at 1 keV verified the presence of Cu. 
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apoptosis-related protein expression in ovaries
To investigate whether Cu NPs induced apoptosis and ovarian injury, the expression levels of apoptosis-related proteins (caspase 3, caspase 8, caspase 9, cytochrome c, Apaf-1, tBid, Bcl-2, and Bax) were examined in the ovarian tissues from rats with or without exposure to Cu NPs. As shown in Figure 7 , our results showed that the expression levels of caspase 8, caspase 3, and caspase 9 proteins in the ovaries were significantly promoted by the different doses of Cu NPs (12.5, 6.25, and 3.125 mg/kg/d) in comparison with the control. Furthermore, the Cu NPs induced dramatic increases in the expression of Bax, tBid, cytochrome c, and Apaf-1, and the expression of Bcl-2 was obviously suppressed by Cu NPs.
Gene expression profile
The global gene expression profiling using mRNAs from ovarian tissues, including the control group and the rats treated with 12.5 mg/kg/d Cu NPs, was analyzed using a microarray. The treated group was compared with the vehicle control under these criteria: log2-fold change .1 or ,1 and P,0.05. The results showed that 321 genes were significantly changed following Cu NP treatment. Of the altered genes, 180 and 141 genes were upregulated (Table S1 ) and downregulated (Table S2) , respectively. According to the 
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qrT-Pcr
To validate the accuracy of the microarray results, several genes with significantly different expression patterns, including Hsd17b1, Hsd3b1, Hsd3b6, Hsd3b, Mt3, and Cebpb, were further investigated using qRT-PCR due to their association with steroid biosynthetic processes and apoptosis. The Hsd17b1 and Mt3 genes were upregulated, whereas Hsd3b1, Hsd3b6, Hsd3b, and Cebpb were downregulated. The qRT-PCR analysis of all genes displayed expression patterns consistent with the microarray data (ie, either upregulation or downregulation; Table 5 ).
Discussion
To the best of our knowledge, this is the first study to focus on the effect of Cu NPs on reproductive toxicity in vivo. Our findings indicated that intraperitoneal injection of 12.5 mg/kg/d Cu NPs for 14 consecutive days led to overt toxicity. Exposure to Cu NPs can decrease the coefficient of ovary weight to BW and accumulate in the ovaries, which in turn induces follicular atresia and apoptosis. Moreover, we observed irregularity of the nuclear membrane, mitochondrial GO analysis, these genes were closely involved in oxidative stress, the cell cycle, steroid hormone biosynthesis, apoptotic processes, cell proliferation, stress responses, signal transduction, and so on (Figure 8 ).
swelling, and cristae breakage. The mitochondrial swelling indicated that Cu NPs enter the cell, bind to the mitochondria, and result in structural changes to the mitochondria and subsequent effects. Our findings indicated that the folliculogenesis inhibition and ovarian damage may be triggered by Cu NPs altering female hormone levels and ovarian gene expression, the activation of apoptogenic factors and apoptosis-inducing factor, and reactive oxygen species (ROS) accumulation. This led to the disruption of ovarian tissue and apoptosis. Therefore, we considered the possible mechanisms of the in vivo ovarian damage caused by treatment with Cu NPs.
According to Amorim et al, 29 chronic exposure of E. albidus worms to Cu NPs resulted in lower reproductive output compared to exposure to CuCl 2 salt. Follicular development is closely related to levels of sex hormones. Gao et al 24 reported that exposure to TiO 2 NPs significantly decreased serum levels of P, LH, T, and FSH and increased the concentration of E 2 . In partial agreement with that study, our results showed that exposure to Cu NPs significantly decreased serum concentrations of FSH, LH, and P and had no effect on the secretion of E 2 . It is known that E 2 plays a vital role in regulating the differentiation of granulosa cells and gonadotropin secretion, 35 and FSH and LH are the main components of the hypothalamic-pituitary-gonadal axis and play a critical role in regulating reproductive function. In female reproduction, P plays pivotal roles in ovulation, implantation, and maintenance of pregnancy. 36 Therefore, the 
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Ovarian toxicity of cu NPs inhibition of follicular development and follicular atresia caused by Cu NP exposure were associated with the alteration of FSH, LH, and P levels. Follicular atresia is not only the breakdown of ovarian follicles but also a kind of cell apoptosis. As the TUNEL assay is considered a reliable method for the evaluation of apoptosis, we used this technique to verify apoptosis and this revealed that Cu NPs induced apoptotic cell death in ovarian tissue.
Oxidative stress has been associated with induction of cell death by apoptosis or necrosis. [37] [38] [39] To further verify ovarian apoptosis, we examined SOD production and MDA accumulation in the ovaries. Oxidative stress and lipid peroxidation have been shown to be important mechanisms of cytotoxicity associated with NPs. 38 Our results indicated that the levels of MDA, a product of lipid peroxidation, were significantly higher in the ovaries of the rats treated with the Cu NPs, whereas the levels of the antioxidant SOD were significantly lower, suggesting that the ovaries of the rats treated with Cu NPs had undergone severe oxidative stress. These results were in agreement with previous studies. For instance, Wang et al 40 demonstrated that exposure to Cu NPs significantly increased ROS and MDA levels in hepatocytes and decreased the total superoxide dismutase (T-SOD) activity. Another work indicated that exposure to nano-Cu increased the production of ROS and induced oxidative stress and apoptosis in kidney tissue. 41 In our study, an increase in lipid peroxidation and disruption of the antioxidant system in the ovaries following exposure to Cu NPs were verified by the enhancement of MDA and the reduction of SOD, respectively. Therefore, we speculated that the process of ovarian apoptosis induced by Cu NPs may be mediated by the mitochondria-initiated pathway.
42,43
Figure 6
Percentages of apoptotic cells in ovaries after rats were exposed to different doses of cu NPs. Notes: Values are expressed as mean ± sD, n=6. **P,0.01: when compared with control group. Abbreviations: cu, copper; cu NPs, copper nanoparticles; med, medium; sD, standard deviation. 
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Yang et al Furthermore, apoptosis, or programmed cell death, is a genetically controlled and highly organized type of cell death that can be mediated by different stimuli via two main signaling pathways: the mitochondria-initiated intrinsic pathway and the death-receptor-mediated extrinsic apoptotic pathway, which triggers a cascade reaction mediated by caspase 8 activation. 28, 44, 45 The evidence suggests that the Bcl-2 family proteins, including pro-apoptotic proteins (eg, Bax and tBid) or antiapoptotic protein (eg, Bcl-2), can be regarded as crucial elements of mitochondria-mediated apoptosis. [46] [47] [48] When 
5969
Ovarian toxicity of cu NPs the expression of Bcl-2 protein is decreased and the expression of Bax protein is increased, mitochondrial membrane potential declines due to the destruction of the mitochondrial membrane. This contributes to the release of cytochrome c from the mitochondria to the cytosol. Then, a cascade reaction occurs, which includes cytochrome binding with Apaf-1 resulting in the activation of the initiator caspase 9 and triggering the activation of the effector caspase 3. It has been well established that nano-Cu triggers both extrinsic and intrinsic apoptotic pathways in oxidative stress-mediated kidney injury. 41 Similarly, our study confirmed that Cu NPs induced mitochondria-initiated intrinsic cell death. Our results showed that the rats treated with Cu NPs exhibited downregulation of Bcl-2 proteins and upregulation of the Bax protein, leading to the release of cytochrome c from the mitochondria to the cytosol. Furthermore, Cu NP exposure induced the expression of cytochrome c, Apaf-1, caspase 9, and caspase 3 and also significantly increased caspase 8 and tBid levels. Taken together, our results strongly indicate that Cu NPs induce apoptosis in the ovaries via both extrinsic and intrinsic pathways.
Cu NP-induced ovarian injury and hormonal changes in female rats may be associated with the alterations in ovarian gene expression. Therefore, we analyzed microarray data and found that 321 genes (180 upregulated and 141 downregulated) were significantly altered by exposure to Cu NPs, and these genes were involved in oxidative stress, the cell cycle, steroid biosynthetic processes, the apoptotic process, cell proliferation, stress responses, signal transduction, and so on. Many genes are critical for the apoptotic process, such as Mt3 and Cebpb. Interestingly, our data showed that Mt3 was significantly upregulated and Cebpb was obviously downregulated in the ovaries of rats treated with 12.5 mg/kg/d of Cu NPs. Moreover, increased expression of Mt3 and decreased expression of Cebpb were further verified by qRT-PCR. Evidence has shown that metallothioneins (MTs) play vital roles in protecting against DNA damage and apoptosis, and these proteins are often divided into four classes (MT1-4). 49 MT3 has been identified as a growth inhibitor factor that could inhibit neuritis formation and survival in neurons. 50 Overexpression of MT3 may inhibit proliferation and induce apoptosis. 37 The transcription factor of the leucine zipper basic region CCAAT/enhancer-binding protein b (C/EBPB) is a member of the C/EBP family. [51] [52] [53] [54] Evidence has indicated that C/EBPB regulates cell differentiation, survival, proliferation, and metabolic processes by inhibition or activation of the target genes. A recent study showed that cells underwent accelerated apoptosis in Cebpbdeficient mice. 55 Therefore, increased Mt3 and decreased Cebpb expression upon exposure to Cu NPs may induce apoptosis and follicular atresia in the ovaries.
Furthermore, some of the pathways identified through the kyoto encyclopedia of genes and genomes (KEGG) pathway analysis are associated with viral diseases. In this study, our rats were treated with Cu NPs, the reaction caused by this treatment is similar to that induced by the antigen, such as viral. The virus is also an antigen for the host. Additionally, the pathway studies of viral infection are relatively more in the KEGG database. Therefore, the change in pathway exposed to Cu NPs is similar to viral infection. Additionally, differentially expressed genes involved in viral infection also participated in other pathways, like phagosome, cell adhesion molecules (CAMs), endocytosis, etc.
Although we have shown that the exposure of rats to Cu NPs for 14 days can cause ovarian injury, we also realize that this study is not without limitations. First, the chronic toxicity of Cu NPs on the reproductive system remains unclear. Second, we only preliminarily explored the possible mechanism of Cu-induced ovarian damage, and the specific underlying molecular mechanism still needs further study.
Conclusion
We have demonstrated that Cu NPs can enter and accumulate in rat ovaries, which in turn can result in ovarian damage, follicular atresia, oxidative stress, apoptosis and apoptotic signaling activation at the protein level, and Cu NP-induced apoptosis involving both mitochondria-dependent and mitochondria-independent cell-death pathways. Moreover, ovarian dysfunction following exposure to Cu NPs may be mainly associated with steroid and hormone metabolic processes, as well as significant alterations in the expression of genes involved in apoptosis. Our findings imply that exposure to Cu NPs should be of concern. Therefore, caution should be exercised in the application of Cu NPs in various areas.
